Salmeterol Fluticasone Propionate (Advair, Wixela Inhub) shortage status
Shortage anticipated
Source: Health Canada shortage reports · Updated Aug 5, 2026
A shortage of Salmeterol Fluticasone Propionate is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A combination inhaler with a long-acting bronchodilator and a corticosteroid used to control asthma and COPD.
Products affected
0 / 7
Reports on file
23
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
WIXELA INHUB
500MCG
50MCG · POWDER · MYLAN PHARMACEUTICALS ULC
DIN 02495619 · Disruption of the manufacture of the drug.
DIN 02245126 · ended May 17, 2022 · Delay in shipping of the drug.
Resolved
WIXELA INHUB
50MCG
500MCG · POWDER · MYLAN PHARMACEUTICALS ULC
DIN 02495619 · ended Mar 15, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Salmeterol Fluticasone Propionate to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Salmeterol Fluticasone Propionate is classified under “ADRENERGICS, INHALANTS” (ATC R03AK).
Recent changes
Aug 5, 2026
New report filed
Common questions
What is Salmeterol Fluticasone Propionate used for?
A combination inhaler with a long-acting bronchodilator and a corticosteroid used to control asthma and COPD.
When will Salmeterol Fluticasone Propionate be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Salmeterol Fluticasone Propionate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.